Fnu Kalpina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fnu Kalpina has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Dinesh Kumar
Dow University of Health Sciences, Karachi, Pakistan
3 shared publicationsLaiba Jabeen
Dow University of Health Sciences, Karachi, Pakistan
3 shared publicationsMaimoona Qayyum
Dow University of Health Sciences, Karachi, Pakistan
3 shared publicationsTabia Shujaat
Dow University of Health Sciences, Karachi, Pakistan
3 shared publications- Ahmed Raza
Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan
2 shared publications Eiman Zeeshan
Dow dental College
2 shared publications
Latest Publications
- 11 July 2026
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 40 (9) , 724-731
Mortality trends and demographics due to hypertensive nephrosclerosis in older adults from 1999–2020
Hypertensive Nephrosclerosis (HSN), a progressive kidney disease, has significantly impacted mortality and morbidity, via cardiovascular events, end-stage renal disease, and infections. Despite its clinical and public health impact, comprehensive analyses of U.S. mortality trends remain understudied. We aim to assess trends in Nephrosclerosis-related deaths in the United States (1999-2020). We extracted HSN-related deaths in older adults aged ≥65 years (1999-2020) using the CDC WONDER database [using ICD-10 code: I-12 (Hypertensive renal disease)]. Crude- and age-adjusted mortality rates (CMR and AAMR) per 100,000 population were determined. We used Joinpoint regression to examine changes in trends and average- and annual percentage change (AAPC and APC) overall and then stratified into demographic and geographical subgroups. A total of 519,817 deaths were recorded due to HSN. Overall, the AAMR rose from 21.51 (1999) to 132.03 (2020) [AAPC, 8.80 (95% CI: 6.53 to 12.08)], especially in age-group 85+ (CMR: 203.36). The overall mortality surged the most remarkably between 2011 and 2014 [APC, 34.74 (95% CI: 1.31 to 50.76)]. Males demonstrated higher AAMRs (67.56) than females (48.93). Racially/ethnically, Non-Hispanic (NH) Blacks (117.99), followed by Hispanics (70.22), exhibited increased vulnerability. Geographically, the Western region (65.71) and rural areas (56.88) held the highest mortality burden. State-wise AAMRs ranged between Connecticut to the District of Columbia (28.58 and 85.8, respectively). In conclusion, HSN-related mortality has increased trends over the last two decades. Males, NH Blacks, 85+ age group, individuals from Western region, and rural residents were the high-risk subgroups. These results call for future research to explore the correlation between observed disparities.
- 11 July 2026
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 40 (9) , 724-731
Mortality trends and demographics due to hypertensive nephrosclerosis in older adults from 1999–2020
Hypertensive Nephrosclerosis (HSN), a progressive kidney disease, has significantly impacted mortality and morbidity, via cardiovascular events, end-stage renal disease, and infections. Despite its clinical and public health impact, comprehensive analyses of U.S. mortality trends remain understudied. We aim to assess trends in Nephrosclerosis-related deaths in the United States (1999-2020). We extracted HSN-related deaths in older adults aged ≥65 years (1999-2020) using the CDC WONDER database [using ICD-10 code: I-12 (Hypertensive renal disease)]. Crude- and age-adjusted mortality rates (CMR and AAMR) per 100,000 population were determined. We used Joinpoint regression to examine changes in trends and average- and annual percentage change (AAPC and APC) overall and then stratified into demographic and geographical subgroups. A total of 519,817 deaths were recorded due to HSN. Overall, the AAMR rose from 21.51 (1999) to 132.03 (2020) [AAPC, 8.80 (95% CI: 6.53 to 12.08)], especially in age-group 85+ (CMR: 203.36). The overall mortality surged the most remarkably between 2011 and 2014 [APC, 34.74 (95% CI: 1.31 to 50.76)]. Males demonstrated higher AAMRs (67.56) than females (48.93). Racially/ethnically, Non-Hispanic (NH) Blacks (117.99), followed by Hispanics (70.22), exhibited increased vulnerability. Geographically, the Western region (65.71) and rural areas (56.88) held the highest mortality burden. State-wise AAMRs ranged between Connecticut to the District of Columbia (28.58 and 85.8, respectively). In conclusion, HSN-related mortality has increased trends over the last two decades. Males, NH Blacks, 85+ age group, individuals from Western region, and rural residents were the high-risk subgroups. These results call for future research to explore the correlation between observed disparities.
- Open Access
- 20 March 2026
- Published by Springer Nature in Research Square
Mortality trends and demographics due to hypertensive nephrosclerosis in older adults from 1999 to 2020.
Introduction Hypertensive Nephrosclerosis (HNS), a progressive kidney disease, has significantly impacted mortality and morbidity, via cardiovascular events, end-stage renal disease, and infections. Despite its clinical and public health impact, comprehensive analyses of U.S. mortality trends remain understudied. We aim to assess trends in Nephrosclerosis-related deaths in the United States (1999–2020). Methods We extracted HNS-related deaths in older adults aged ≥ 65 years (1999–2020) using the CDC WONDER database [using ICD-10 code: I-12 (Hypertensive renal disease)]. Crude- and age-adjusted mortality rates (CMR and AAMR) per 100,000 population were determined. We used Joinpoint regression to examine changes in trends and average- and annual percentage change (AAPC and APC) overall and then stratified into demographic and geographical subgroups. Results A total of 519,817 deaths were recorded due to HNS. Overall, the AAMR rose from 21.51 (1999) to 132.03 (2020) [AAPC, 8.80 (95% CI: 6.53 to 12.08)], especially in age-group 85+ (CMR: 203.36). The overall mortality surged the most remarkably between 2011 and 2014 [APC, 34.74 (95% CI: 1.31 to 50.76)]. Males demonstrated higher AAMRs (67.56) than females (48.93). Racially/ethnically, Non-Hispanic (NH) Blacks (117.99), followed by Hispanics (70.22), exhibited increased vulnerability. Geographically, the Western region (65.71) and rural areas (56.88) held the highest mortality burden. State-wise AAMRs ranged between Connecticut to the District of Columbia (28.58 and 85.8, respectively). Conclusion HNS-related mortality has increased trends over the last two decades. Males, NH Blacks, 85 + age group, individuals from Western region, and rural residents were the high-risk subgroups. These results call for future research to explore the correlation between observed disparities.
- 20 March 2026
- Published by Springer Nature in Research Square
Open AccessMortality trends and demographics due to hypertensive nephrosclerosis in older adults from 1999 to 2020.
Introduction Hypertensive Nephrosclerosis (HNS), a progressive kidney disease, has significantly impacted mortality and morbidity, via cardiovascular events, end-stage renal disease, and infections. Despite its clinical and public health impact, comprehensive analyses of U.S. mortality trends remain understudied. We aim to assess trends in Nephrosclerosis-related deaths in the United States (1999–2020). Methods We extracted HNS-related deaths in older adults aged ≥ 65 years (1999–2020) using the CDC WONDER database [using ICD-10 code: I-12 (Hypertensive renal disease)]. Crude- and age-adjusted mortality rates (CMR and AAMR) per 100,000 population were determined. We used Joinpoint regression to examine changes in trends and average- and annual percentage change (AAPC and APC) overall and then stratified into demographic and geographical subgroups. Results A total of 519,817 deaths were recorded due to HNS. Overall, the AAMR rose from 21.51 (1999) to 132.03 (2020) [AAPC, 8.80 (95% CI: 6.53 to 12.08)], especially in age-group 85+ (CMR: 203.36). The overall mortality surged the most remarkably between 2011 and 2014 [APC, 34.74 (95% CI: 1.31 to 50.76)]. Males demonstrated higher AAMRs (67.56) than females (48.93). Racially/ethnically, Non-Hispanic (NH) Blacks (117.99), followed by Hispanics (70.22), exhibited increased vulnerability. Geographically, the Western region (65.71) and rural areas (56.88) held the highest mortality burden. State-wise AAMRs ranged between Connecticut to the District of Columbia (28.58 and 85.8, respectively). Conclusion HNS-related mortality has increased trends over the last two decades. Males, NH Blacks, 85 + age group, individuals from Western region, and rural residents were the high-risk subgroups. These results call for future research to explore the correlation between observed disparities.
- 11 December 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 318, 114889
Efficacy and safety of relugolix therapy for symptomatic uterine fibroids: a systematic review and meta-analysis
- 11 December 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 318, 114889
Efficacy and safety of relugolix therapy for symptomatic uterine fibroids: a systematic review and meta-analysis
- Open Access
- 21 July 2025
- Published by Taylor & Francis in Future Cardiology
- Vol. 21 (10) , 769-778
Concurrent aortic stenosis and hypertension: mortality trends in US older adults from 1999–2020
Aortic Stenosis (AS) is a valvular heart disease. Hypertension accelerates stenosis, increasing morbidity and mortality. This study investigates mortality trends in US older adults with AS and hypertension from 1999 to 2020. Using the CDC WONDER database, age-adjusted mortality rates (AAMRs) per 100,000 individuals aged 65+ with AS and hypertension were analyzed. Changes in AAMRs were examined through annual percent change (APC) and average APC (AAPC) using Joinpoint regression. From 1999 to 2020, hypertension caused 99,250 deaths in AS patients in the US, demonstrating an increasing trend (AAPC: 5.51%). Males had higher AAMRs (11.51) than females (9.99). Non-Hispanic (NH) white people (11.32) had the highest AAMRs, followed by Hispanic (7.37), NH Black people (7.27), and NH Asians (6.12). Regionally, the West showed the highest AAMR (13.3), followed by the Midwest (11.38), the Northeast (10.62), and the South (8.53). The states with the highest AAMRs were Vermont and Oregon, while Alabama and Georgia had the lowest. Non-metropolitan areas (11.19) experienced higher mortality than metropolitan areas (10.49). We report increasing mortality rates in patients with AS and hypertension, especially in males, NH white people, and the West. Target healthcare measures are needed to address the rising mortality.
- 21 July 2025
- Published by Taylor & Francis in Future Cardiology
- Vol. 21 (10) , 769-778
Open AccessConcurrent aortic stenosis and hypertension: mortality trends in US older adults from 1999–2020
Aortic Stenosis (AS) is a valvular heart disease. Hypertension accelerates stenosis, increasing morbidity and mortality. This study investigates mortality trends in US older adults with AS and hypertension from 1999 to 2020. Using the CDC WONDER database, age-adjusted mortality rates (AAMRs) per 100,000 individuals aged 65+ with AS and hypertension were analyzed. Changes in AAMRs were examined through annual percent change (APC) and average APC (AAPC) using Joinpoint regression. From 1999 to 2020, hypertension caused 99,250 deaths in AS patients in the US, demonstrating an increasing trend (AAPC: 5.51%). Males had higher AAMRs (11.51) than females (9.99). Non-Hispanic (NH) white people (11.32) had the highest AAMRs, followed by Hispanic (7.37), NH Black people (7.27), and NH Asians (6.12). Regionally, the West showed the highest AAMR (13.3), followed by the Midwest (11.38), the Northeast (10.62), and the South (8.53). The states with the highest AAMRs were Vermont and Oregon, while Alabama and Georgia had the lowest. Non-metropolitan areas (11.19) experienced higher mortality than metropolitan areas (10.49). We report increasing mortality rates in patients with AS and hypertension, especially in males, NH white people, and the West. Target healthcare measures are needed to address the rising mortality.